Mitsubishi UFJ Asset Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
CC
Mitsubishi UFJ Asset Management's PRCT Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management increased its Procept Biorobotics (PRCT) stake by 3.8% in Q2 2026, buying an estimated $192K and bringing the position to 212,427 shares worth $4.8M. The position accounts for ﹤0.01% of the portfolio, ranked #680.
Mitsubishi UFJ Asset Management first reported a position in PRCT in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.21M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.
- Mitsubishi UFJ Asset Management held 212,427 shares of Procept Biorobotics worth $4.8M as of Q2 2026.
- Mitsubishi UFJ Asset Management bought 7,685 Procept Biorobotics shares in Q2 2026, an estimated $192K.
- Procept Biorobotics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #680 holding.
- Mitsubishi UFJ Asset Management first reported a position in Procept Biorobotics in Q2 2022 and has held it in 17 quarters since.
- Mitsubishi UFJ Asset Management's Procept Biorobotics position peaked at $9.21M in Q2 2025.
- 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.